PDEX
Neutral signalScored 2026-09-14 Drivers: fundamentals. Moteurs : fondamentaux.
Research, not advice.
À propos
Pro-Dex, Inc.
- Nom
- Pro-Dex, Inc.
- Secteur
- Healthcare
- Industrie
- Medical - Instruments & Supplies
- Bourse
- NASDAQ
- Capitalisation
- $201.2M
- Employés
- 204
- PDG
- Richard Lee Van Kirk Jr.
- Site web
- https://www.pro-dex.com
- Marché
- APYXCGTXGLSIIXHLLUCDMBOT
Pro-Dex, Inc. focuses on the development and manufacturing of advanced motorized surgical instruments. These sophisticated tools are supplied globally to original equipment manufacturers (OEMs) in the medical device sector. Their product portfolio features versatile, autoclavable (sterilization-friendly) surgical drivers and shavers, available in both battery-powered and electric models, often equipped with multi-functional capabilities. These instruments are primarily employed in orthopedic, thoracic, and craniomaxillofacial surgical procedures. Beyond its core manufacturing, Pro-Dex also offers expert consulting services, covering engineering, quality assurance, and regulatory compliance. Furthermore, the company manufactures and distributes rotary air motors to various industrial clients. Founded in 1978, Pro-Dex, Inc. maintains its corporate headquarters in Irvine, California.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
VENTE TOTALE: 20 000 titres (~1 178 415,30 $ US)
- Insiders
- Van Kirk Richard Lee Jr
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$361,185
Avg sell (VWAP, 90d window) $59.77 vs last close —
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
$311,777 of that total is under a Rule 10b5-1 plan. It is shown here and left out of the score.
- Last activity
- 2026-09-11
- Last synced
-
2026-09-17 09:54:31
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-09-11 | Van Kirk Richard Lee Jr | Sell · S · 10b5-1 | 475 | $59.62 | $28,320 | Form 4 |
| 2026-09-09 | Charlton Alisha | Sell · S | 800 | $61.76 | $49,408 | Form 4 |
| 2026-09-09 | Van Kirk Richard Lee Jr | Sell · S · 10b5-1 | 4,768 | $59.45 | $283,458 | Form 4 |
Sales marked 10b5-1 are scheduled in advance and don't count toward the Quorum score. Les ventes marquées 10b5-1 sont planifiées à l'avance et ne pèsent pas dans le score Quorum.
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Signal
Neutral signalScored 2026-09-14 Drivers: fundamentals. Moteurs : fondamentaux.
PDEX exhibits strong financial health with solid liquidity (90) and improving fundamentals (85), but the catalyst score is critically low (20) with no actionable event-driven signal to justify near-term entry.
The first sentence of the analysis written for PDEX on 2026-09-14 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
- Timing Unavailable or mixed. No stored price series
- Financial indicators Supports a bullish reading. Current ratio 4.10 · operating margin 17%
Market snapshot
Financial ratios
| Metric | Trend | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 31.4% | 29.3% | 27.0% | 27.7% | 31.2% | |
| Ebit Margin | 16.8% | 19.4% | 5.9% | 21.6% | 14.6% | |
| Ebitda Margin | 18.5% | 21.2% | 8.1% | 23.5% | 16.4% | |
| Operating Profit Margin | 16.8% | 16.1% | 13.3% | 12.5% | 12.2% | |
| Pretax Profit Margin | 23.2% | 18.1% | 4.9% | 20.5% | 13.5% | |
| Continuous Operations Profit Margin | 17.6% | 13.5% | 4.0% | 15.3% | 10.9% | |
| Net Profit Margin | 17.6% | 13.5% | 4.0% | 15.3% | 10.9% | |
| Bottom Line Profit Margin | 17.6% | 13.5% | 4.0% | 15.3% | 10.9% | |
| Current Ratio | 4.101 | 3.233 | 2.840 | 3.202 | 2.745 | |
| Quick Ratio | 2.449 | 1.715 | 1.655 | 1.531 | 1.628 | |
| Solvency Ratio | 0.560 | 0.416 | 0.152 | 0.392 | 0.224 | |
| Cash Ratio | 0.631 | 0.029 | 0.204 | 0.303 | 0.075 | |
| Price To Earnings Ratio | 13.809 | 15.985 | 30.082 | 9.646 | 12.659 | |
| Price To Earnings Growth Ratio | 0.250 | 0.046 | -0.435 | 0.169 | 1.646 | |
| Forward Price To Earnings Growth Ratio | 0.250 | 0.046 | -0.435 | 0.169 | 1.646 | |
| Price To Earnings Diluted Ratio | 14.211 | 16.345 | 30.583 | 9.795 | 13.182 | |
| Price To Earnings Diluted Growth Ratio | 0.262 | 0.047 | -0.442 | 0.160 | 1.862 | |
| Price To Book Ratio | 3.965 | 3.917 | 2.080 | 2.159 | 2.280 | |
| Price To Sales Ratio | 2.436 | 2.155 | 1.192 | 1.480 | 1.379 | |
| Price To Free Cash Flow Ratio | 27.944 | -49.003 | 12.309 | 15.198 | -23.031 | |
| Price To Operating Cash Flow Ratio | 26.081 | -85.304 | 10.357 | 12.488 | -68.468 | |
| Debt To Assets Ratio | 0.243 | 0.271 | 0.258 | 0.285 | 0.325 | |
| Debt To Equity Ratio | 0.380 | 0.453 | 0.439 | 0.468 | 0.628 | |
| Debt To Capital Ratio | 0.275 | 0.312 | 0.305 | 0.319 | 0.386 | |
| Long Term Debt To Capital Ratio | 0.218 | 0.202 | 0.196 | 0.220 | 0.287 | |
| Financial Leverage Ratio | 1.564 | 1.670 | 1.700 | 1.640 | 1.930 | |
| Working Capital Turnover Ratio | 2.127 | 2.362 | 2.392 | 2.242 | 2.122 | |
| Operating Cash Flow Ratio | 0.558 | -0.115 | 0.481 | 0.564 | -0.075 | |
| Operating Cash Flow Sales Ratio | 0.093 | -0.025 | 0.115 | 0.119 | -0.020 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.933 | 1.741 | 0.841 | 0.822 | 2.973 | |
| Debt Service Coverage Ratio | 2.000 | 1.583 | 0.780 | 1.941 | 1.537 | |
| Interest Coverage Ratio | 15.999 | 12.894 | 12.855 | 10.811 | 11.041 | |
| Short Term Operating Cash Flow Coverage Ratio | 1.722 | -0.274 | 1.417 | 1.427 | -0.258 | |
| Operating Cash Flow Coverage Ratio | 0.400 | -0.101 | 0.458 | 0.369 | -0.053 | |
| Capital Expenditure Coverage Ratio | 14.994 | -1.350 | 6.306 | 5.608 | -0.507 | |
| Dividend Paid And Capex Coverage Ratio | 14.994 | -1.350 | 6.306 | 5.608 | -0.507 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 13.819 | 11.301 | 17.261 | 7.401 | 10.620 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 31.4% | ▲2.1% | ▲2.1% |
| Ebit Margin | 16.8% | ▼-2.6% | ▲1.1% |
| Ebitda Margin | 18.6% | ▼-2.7% | ▲1.0% |
| Operating Profit Margin | 16.8% | ▲0.7% | ▲2.6% |
| Pretax Profit Margin | 23.2% | ▲5.1% | ▲7.2% |
| Continuous Operations Profit Margin | 17.6% | ▲4.1% | ▲5.4% |
| Net Profit Margin | 17.6% | ▲4.1% | ▲5.4% |
| Bottom Line Profit Margin | 17.6% | ▲4.1% | ▲5.4% |
| Current Ratio | 4.101 | ▲0.868 | ▲0.877 |
| Quick Ratio | 2.449 | ▲0.734 | ▲0.653 |
| Solvency Ratio | 0.560 | ▲0.144 | ▲0.211 |
| Cash Ratio | 0.631 | ▲0.602 | ▲0.383 |
| Price To Earnings Ratio | 13.809 | ▼-2.176 | ▼-2.627 |
| Price To Earnings Growth Ratio | 0.250 | ▲0.204 | ▼-0.085 |
| Forward Price To Earnings Growth Ratio | 0.250 | ▲0.204 | ▼-0.085 |
| Price To Earnings Diluted Ratio | 14.211 | ▼-2.133 | ▼-2.612 |
| Price To Earnings Diluted Growth Ratio | 0.262 | ▲0.214 | ▼-0.116 |
| Price To Book Ratio | 3.965 | ▲0.048 | ▲1.085 |
| Price To Sales Ratio | 2.436 | ▲0.281 | ▲0.707 |
| Price To Free Cash Flow Ratio | 27.944 | ▲76.948 | ▲31.261 |
| Price To Operating Cash Flow Ratio | 26.081 | ▲111.385 | ▲47.050 |
| Debt To Assets Ratio | 0.243 | ▼-0.028 | ▼-0.034 |
| Debt To Equity Ratio | 0.380 | ▼-0.073 | ▼-0.094 |
| Debt To Capital Ratio | 0.275 | ▼-0.036 | ▼-0.044 |
| Long Term Debt To Capital Ratio | 0.218 | ▲0.016 | ▼-0.007 |
| Financial Leverage Ratio | 1.564 | ▼-0.106 | ▼-0.137 |
| Working Capital Turnover Ratio | 2.127 | ▼-0.235 | ▼-0.122 |
| Operating Cash Flow Ratio | 0.558 | ▲0.673 | ▲0.275 |
| Operating Cash Flow Sales Ratio | 0.093 | ▲0.119 | ▲0.037 |
| Free Cash Flow Operating Cash Flow Ratio | 0.933 | ▼-0.807 | ▼-0.529 |
| Debt Service Coverage Ratio | 2.000 | ▲0.416 | ▲0.431 |
| Interest Coverage Ratio | 15.999 | ▲3.105 | ▲3.279 |
| Short Term Operating Cash Flow Coverage Ratio | 1.722 | ▲1.996 | ▲0.915 |
| Operating Cash Flow Coverage Ratio | 0.400 | ▲0.502 | ▲0.186 |
| Capital Expenditure Coverage Ratio | 14.994 | ▲16.344 | ▲9.984 |
| Dividend Paid And Capex Coverage Ratio | 14.994 | ▲16.344 | ▲9.984 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 13.819 | ▲2.518 | ▲1.738 |
Key metrics
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Market cap | $188.9M | $143.5M | $64.2M | $68.2M | $58.0M | |
| Enterprise value | $198.8M | $159.6M | $75.1M | $80.1M | $73.1M | |
| EV / Sales | 2.56x | 2.40x | 1.40x | 1.74x | 1.74x | |
| EV / Op. cash flow | 27.45x | -94.91x | 12.12x | 14.66x | -86.32x | |
| EV / Free cash flow | 29.41x | -54.52x | 14.40x | 17.84x | -29.04x | |
| EV / EBITDA | 13.82x | 11.30x | 17.26x | 7.40x | 10.62x | |
| Net debt / EBITDA | 0.69x | 1.14x | 2.51x | 1.10x | 2.20x | |
| Current ratio | 4.10x | 3.23x | 2.84x | 3.20x | 2.75x | |
| Income quality | 0.53x | -0.19x | 2.91x | 0.77x | -0.18x | |
| Graham number | $38 | $26 | $11 | $20 | $14 | |
| Graham net-net | $3 | $2 | $1 | -$0 | -$1 | |
| Tax burden | 75.8% | 74.5% | 80.8% | 75.0% | 80.3% | |
| Interest burden | 138.7% | 93.6% | 82.5% | 94.6% | 92.5% | |
| Working capital | $40.3M | $32.7M | $23.7M | $21.3M | $19.8M | |
| Invested capital | $48.1M | $33.7M | $36.4M | $34.6M | $33.4M | |
| Return on assets | 18.3% | 14.7% | 4.1% | 13.7% | 9.3% | |
| Operating ROA | 19.1% | 18.8% | 13.8% | 11.4% | 10.4% | |
| Return on tangible assets | 20.3% | 14.7% | 4.1% | 13.7% | 9.3% | |
| Return on equity | 28.7% | 24.5% | 6.9% | 22.4% | 18.0% | |
| Return on invested capital | 15.0% | 15.0% | 13.0% | 9.3% | 9.9% | |
| Return on capital employed | 21.1% | 23.0% | 18.1% | 13.7% | 13.6% | |
| Earnings yield | 7.2% | 6.3% | 3.3% | 10.4% | 7.9% | |
| Free cash flow yield | 3.6% | -2.0% | 8.1% | 6.6% | -4.3% | |
| Capex / Op. cash flow | 6.7% | -74.1% | 15.9% | 17.8% | -197.3% | |
| Capex / Depreciation | 34.6% | 100.6% | 84.7% | 113.7% | 230.2% | |
| Capex / Sales | 0.6% | 1.9% | 1.8% | 2.1% | 4.0% | |
| SG&A / Sales | 10.3% | 7.8% | 7.8% | 9.1% | 11.9% | |
| R&D / Sales | 4.3% | 5.5% | 5.9% | 6.1% | 7.1% | |
| Stock comp / Sales | 0.9% | 0.8% | 1.1% | 1.7% | 3.0% | |
| Intangibles / Total assets | 9.7% | 0.0% | 0.1% | 0.2% | 0.2% | |
| Days sales outstanding | 100d | 96d | 94d | 79d | 134d | |
| Days payables outstanding | 29d | 36d | 42d | 25d | 47d | |
| Operating cycle | 247d | 268d | 236d | 256d | 294d | |
| Cash conversion cycle | 218d | 232d | 194d | 231d | 246d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years